Patent · US Active

Multi-phase emulsions based on amphiphilic block copolymers

US8444993B2 · kind B2 · utility

5Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 5, 2012
Grant dateMay 21, 2013
Priority date
Expiry dateSep 5, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for enhancing a body's response to an immunogen is disclosed. The method comprises immunizing a subject in need thereof a vaccine composition in a water-in-oil (W/O/W) emulsion that comprises (a) an antigen; and (b) an adjuvant composition in a W/O/W emulsion. The adjuvant composition comprises: (i) a continuous aqueous phase comprising H2O; (ii) an oil phase comprising oil dispersed in the continuous aqueous phase, comprising an internal aqueous phase comprising H2O, being dispersed in the oil phase; and a physiologically acceptable lipophilic emulsifier selected from the group consisting of mannide monooleate and sorbitan esters, stabilizing the interface between the inner aqueous phase and the oil phase to form a water-in-oil (W/O) emulsion; and (iii) poly(ethylene glycol)-block-poly(lactide-co-ε-caprolactone), stabilizing the interface between the oil phase and the continuous aqueous phase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.